title: Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma.
authors.forename: A
authors.initials: A
authors.lastname: Younes
authors.forename: F
authors.initials: F
authors.lastname: Wong
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D016499:Radioimmunotherapy; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan